BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8403060)

  • 21. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
    Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The choice of an adequate method for treating lung cancer taking into account the tumor growth rate].
    Diusembaev ZE
    Med Radiol (Mosk); 1991; 36(11):30-3. PubMed ID: 1658531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of the small-cell and poorly differentiated forms of squamous-cell and glandular lung cancers].
    Pirogov AI; Polotskiĭ BE; Al-Ansari N; Volkov SM; Popesku KF
    Vopr Onkol; 1989; 35(2):154-8. PubMed ID: 2467441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An analysis of the therapeutic effects of 120 cases of lung cancer in the elderly].
    Xu YN
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Dec; 8(6):321-4, 372. PubMed ID: 3015519
    [No Abstract]   [Full Text] [Related]  

  • 26. [Surgical indication based on prognostic factors in pT1 tumors of the lung].
    Komatsu H; Katayama T; Murakami K; Sagara Y; Hayashi K
    Kyobu Geka; 1991 Jan; 44(1):61-4. PubMed ID: 1645422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
    Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA
    Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Survival of cervical cancer patients in selected regions of Poland in 1990-1996, in relation to some prognostic factors].
    Bielska-Lasota M; Krynicki R; Rabczenko D; Czerw-Głab K; Starzewski J; Wronkowski Z; Zieliński J; Chil A; Hudała-Klecha J; Swiercz A
    Przegl Epidemiol; 2004; 58(3):523-36. PubMed ID: 15730017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
    Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problems concerning the diagnosis and treatment of multiple primary carcinoma of the lung].
    Kodama K; Doi O; Tatsuta M; Higashiyama M; Iwanaga T
    Kyobu Geka; 1990 Aug; 43(9):682-8,DISCUSSION 689-91. PubMed ID: 2172609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multimodality therapy of late stage lung cancer].
    Liao M; Zhao J; Zhou Y
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):384-6. PubMed ID: 8697983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation between tumor histology and prognostic factors in lung cancer cases].
    Kodama T
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):45-53. PubMed ID: 2981517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathologic features of lung pleomorphic (spindle/giant cell) carcinoma--a report of 17 cases].
    Zhao ZL; Song N; Huang QY; Liu YP; Zhao HR
    Ai Zheng; 2007 Feb; 26(2):183-8. PubMed ID: 17298750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.
    Bréchot JM; Chevret S; Charpentier MC; Appere de Vecchi C; Capron F; Prudent J; Rochemaure J; Chastang C
    Cancer; 1996 Nov; 78(10):2111-8. PubMed ID: 8918404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatments and diagnosis of lung cancer--field study results: report from japan lung cancer TNM classification committee].
    Yoshimura K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):708-14. PubMed ID: 6881994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations].
    Liao ML; Chen ZW; Zheng Y; Wu CX; Lu S; Yu YF; Jian H; Cheng BJ
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1876-80. PubMed ID: 17923007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
    Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
    J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.